title: Efficiency of rituximab in the treatment of autoimmune thrombocytopenic purpura associated with common variable immunodeficiency.
authors.forename: M
authors.initials: M
authors.lastname: Mahévas
authors.forename: L
authors.initials: L
authors.lastname: Le Page
authors.forename: V
authors.initials: V
authors.lastname: Salle
authors.forename: R
authors.initials: R
authors.lastname: Cevallos
authors.forename: A
authors.initials: A
authors.lastname: Smail
authors.forename: P
authors.initials: P
authors.lastname: Duhaut
authors.forename: J P
authors.initials: JP
authors.lastname: Ducroix
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D002648:Child; D017074:Common Variable Immunodeficiency / Q000150:complications*; D005260:Female; D006801:Humans; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000150:complications* / Q000188:drug therapy* / Q000276:immunology; D000069283:Rituximab; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab